Viewing Study NCT05780034


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2026-01-20 @ 2:37 PM
Study NCT ID: NCT05780034
Status: RECRUITING
Last Update Posted: 2025-10-02
First Post: 2023-03-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Sponsor: Accutar Biotechnology Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module